[1]. Drug-refractory Heart Failure in Female Carrier of Duchenne Muscular Dystrophy: A Case of X-linked Dilated Cardiomyopathy.
Intern Med （2023年） [査読] 有
[DOI] [2]. Feasibility of Short-Term Aggressive Lipid-Lowering Therapy with the PCSK9 Antibody in Acute Coronary Syndrome
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE [巻]10 [号]5 （2023年） [査読] 有
[DOI] [3]. Prevalence and Characteristics of Inspiration-Induced Negative Left Atrial Pressure during Pulmonary Vein Isolation.
Journal of cardiovascular development and disease [巻]10 [号]3 （2023年） [査読] 有
[DOI] [4]. A Case of Double Coronary Artery Infarction: Frequent Electrocardiogram Measurement Enables Prediction of the Pathophysiology
INTERNAL MEDICINE [巻]62 [号]14 [頁]2033 -2034 （2023年） [査読] 無
[DOI] [5]. Diagnostic value of heart-to-mediastinum ratio in Tc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology （2022年） [査読] 有
[DOI] [6]. Drug-refractory Heart Failure in Female Carrier of Duchenne Muscular Dystrophy: A Case of X-linked Dilated Cardiomyopathy.
Internal medicine (Tokyo, Japan) （2022年） [査読] 有
[DOI] [7]. Association of an Increased Abnormal Mitochondria Ratio in Cardiomyocytes with a Prolonged Oxygen Uptake Time Constant during Cardiopulmonary Exercise Testing of Patients with Non-ischemic Cardiomyopathy.
Internal medicine (Tokyo, Japan) （2022年） [査読] 有
[DOI] [8]. Individualised left anterior oblique projection for lead implantation into interventricular septum.
Open heart [巻]9 [号]2 （2022年） [査読] 有
[DOI] [9]. Stereoselective interaction of tolvaptan with amiodarone under racemic metabolic impact by CYP3A5 genotypes in heart failure patients.
European journal of clinical pharmacology [巻]78 [号]8 [頁]1311 -1320 （2022年） [査読] 有
[DOI] [10]. Long-term effect of tocilizumab on left ventricular hypertrophy and systolic dysfunction in AA amyloidosis with rheumatoid arthritis.
Journal of cardiology cases [巻]25 [号]3 [頁]177 -181 （2022年） [査読] 有
[DOI] [11]. Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
PloS one [巻]17 [号]4 [頁]e0266939 （2022年） [査読] 有
[DOI] [12]. Multiple Ligation-dependent Probe Amplification Along with Whole Exome Sequencing Should be Required for the Diagnosis of Structural Heterozygous Familial Hypercholesteremia.
Internal medicine (Tokyo, Japan) [巻]61 [号]19 [頁]2829 -2830 （2022年） [査読] 有
[DOI] [13]. Multiple Ligation-dependent Probe Amplification Along with Whole Exome Sequencing Should be Required for the Diagnosis of Structural Heterozygous Familial Hypercholesteremia.
Intern Med. [巻]61 [号]19 [頁]2829 -2830 （2022年） [査読] 無
[DOI] [14]. Long-term effect of tocilizumab on left ventricular hypertrophy and systolic dysfunction in AA amyloidosis with rheumatoid arthritis.
J Cardiol Cases. （2021年） [査読] 有
[DOI] [15]. Intra-Left Ventricular Hemodynamics Assessed with 4D Flow Magnetic Resonance Imaging in Patients with Left Ventricular Thrombus.
Int Heart J. [巻]62 [号]6 [頁]1287 -1296 （2021年） [査読] 有
[DOI] [16]. Intra-Left Ventricular Hemodynamics Assessed with 4D Flow Magnetic Resonance Imaging in Patients with Left Ventricular Thrombus.
International heart journal [巻]62 [号]6 [頁]1287 -1296 （2021年） [査読] 有
[DOI] [17]. Early changes of pulmonary arterial hemodynamics in patients with systemic sclerosis: flow pattern, WSS, and OSI analysis with 4D flow MRI.
European radiology （2020年） [査読] 有
[DOI] [18]. Simple LC-MS/MS method using core-shell ODS microparticles for the simultaneous quantitation of edoxaban and its major metabolites in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [巻]1146 [頁]122121 （2020年） [査読] 有
[DOI] [機関リポジトリ][19]. Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients.
Basic & clinical pharmacology & toxicology [巻]126 [号]4 [頁]353 -363 （2020年） [査読] 有
[DOI] [機関リポジトリ][20]. An enantiomeric quantitative LC-MS/MS method for tolvaptan and its monohydroxylates in human plasma using a reversed-phase separation procedure.
Journal of pharmaceutical and biomedical analysis [巻]180 [頁]113061 （2020年） [査読] 有
[DOI] [21]. Plasma Globotriaosylsphingosine Level as a Primary Screening Target for Fabry Disease in Patients With Left Ventricular Hypertrophy.
Circulation journal : official journal of the Japanese Circulation Society [巻]83 [号]9 [頁]1901 -1907 （2019年） [査読] 有
[DOI] [22]. Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance.
International journal of molecular sciences [巻]20 [号]16 （2019年） [査読] 有
[DOI] [23]. Pinacidil, a KATP channel opener, stimulates cardiac Na/Ca exchanger function through the NO/cGMP/PKG signaling pathway in guinea pig cardiac ventricular myocytes.
Naunyn-Schmiedeberg's archives of pharmacology [巻]392 [号]8 [頁]949 -959 （2019年） [査読] 有
[DOI] [24]. Cardiac Insulin Resistance in Heart Failure: The Role of Mitochondrial Dynamics.
International journal of molecular sciences [巻]20 [号]14 （2019年） [査読] 有
[DOI] [25]. Cardiotoxicity of Carfilzomib in Two Japanese Patients with Relapsed Multiple Myeloma.
Internal medicine (Tokyo, Japan) [巻]58 [号]11 [頁]1577 -1581 （2019年） [査読] 有
[DOI] [26]. Validated liquid chromatography coupled to tandem mass spectrometry method for simultaneous quantitation of tolvaptan and its five major metabolites in human plasma.
Annals of clinical biochemistry [巻]56 [号]3 [頁]387 -396 （2019年） [査読] 有
[DOI]